A federal lawyer heart two hours of oral arguments Friday from a lawyer representing two union health plans, accusing drug makers of fraud for coupons offered to consumers on brand name drugs. While the drug companies motioned to dismiss the two class actions, US District Judge Paul Oetken pressed the lawyer to explain how the coupons violated the law; according to reports, the coupons are accused to be “undisclosed kickbacks” and “commercial bribery” in violation of antitrust law intended to keep consumers on brand name drugs, often more expensive than their generic counterparts. According to the plaintiffs, the drug makers are utilizing coupons to preserve their market shares. According to reports, the Judge did not seem entirely convinced of the claims made.
Full Content: Thomson Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI